Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01883050 · ClinicalTrials.gov registry record · NA

Application for Self-Monitoring of Cardiovascular Risk

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT01883050: Completed NA study, sponsored by Mayo Clinic.

NCT01883050 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01883050, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

Patients who recently suffered a heart attack will use a smart-phone/computer application during cardiac rehabilitation to reduce their risk of a future attack, their re-hospitalizations, their cost of care, and increase their quality of life.

Primary Outcome

These data will provide the best summary of usability of the application.

Interventions

  • DEVICE Self Monitoring Software Application

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2013-05
Est. Completion 2015-06
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT01883050 record still lists

NCT01883050 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which Self Monitoring Software Application is the first listed.

NCT01883050 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01883050 about?

NCT01883050 is a clinical study titled "Application for Self-Monitoring of Cardiovascular Risk". Patients who recently suffered a heart attack will use a smart-phone/computer application during cardiac rehabilitation to reduce their risk of a future attack, their re-hospitalizations, their cost of care, and increase their quality of life.

What is the current status of trial NCT01883050?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2013-05. Estimated completion is 2015-06.

What interventions are being tested in trial NCT01883050?

The interventions under investigation include: Self Monitoring Software Application (DEVICE).

Who is sponsoring clinical trial NCT01883050?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01883050's enrollment target sits among peer trials

80 994th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01883050, the US trial registry maintained by the National Library of Medicine. NCT01883050 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.